|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/32 | |
| G01N 33/574 |
| (11) | Number of the document | 2558501 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11716143.0 |
| Date of filing the European patent application | 2011-04-14 | |
| (97) | Date of publication of the European application | 2013-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/032590 |
| Date | 2011-04-14 |
| (87) | Number | WO 2011/130580 |
| Date | 2011-10-20 |
| (30) | Number | Date | Country code |
| 324490 P | 2010-04-15 | US |
| (72) |
ALPER, Ozge, US
|
| (73) |
Alper Biotech, LLC,
9700 Great Seneca Highway Suite 188, Rockville, Maryland 20850,
US
|
| (54) | MONOCLONAL ANTIBODIES AGAINST HER2 ANTIGENS, AND USES THEREFOR |
| MONOCLONAL ANTIBODIES AGAINST HER2 ANTIGENS, AND USES THEREFOR |